跳至主要内容
临床试验/DRKS00028901
DRKS00028901招募中不适用

Evaluation of imaging biomarkers and longitudinal assessment of global and regional cardiac function by cardiac MRI during recovery from COVID-19 infection in a multicenter normalized cohort - NAHAP-KAM

Klinikum der Universität München, Campus Großhadern0 个研究点目标入组 150 人开始时间: 2022年6月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • All patients (age: >18 years, no gender or ethnicity restrictions) who underwent one or more cardiac MRI examination(s) as a result of detected COVID-19 acquisition (PCR test) in the NAPKON HAP cohort will be included in the analysis.

排除标准

  • - Patients without an existing cardio-MRI examination.
  • - Lack of evidence of COVID-19 disease.
  • - Contraindication to MR imaging (metal, renal insufficiency, lack of compliance)

研究者

发起方
Klinikum der Universität München, Campus Großhadern

相似试验